Page last updated: 2024-11-13

lucensomycin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

Lucensomycin: A macrolide antibiotic isolated from cultures of Streptomyces lucensis. [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID118984381
MeSH IDM0012719

Synonyms (30)

Synonym
lucimycin
nsc 143257
stereoisomer of 22-((3-amino-3,6-dideoxy-beta-d-mannopyranosyl)oxy)-12-butyl-1,3,26-trihydroxy-10-oxo-6,11,28-trioxatricyclo(33.3.1.05,7)octacosa-8,14,16,18,20-pentaene-25-carboxylic acid
6,11,28-trioxatricyclo(22.3.1.05,7)octacowq-8,14,16,18,20-pentaene-25-carboxylic acid, 22-((3-amino-3,6-dideoxy-beta-d-mannopyranosyl)oxy)-12-butyl-1,3,26-trihydroxy-10-oxo-
fi 1163
einecs 235-950-7
etruscomycin
etruscomicina
antibiotic obtained from cultures of streptomyces lucensis, or the same substance produced by any other means
nsc-143257
lucensomycin
3k1b4b63d0 ,
lucimycinum [inn-latin]
unii-3k1b4b63d0
leusensomycin
antibiotic 1163 f.i.
lucimycine [inn-french]
13058-67-8
lucimycinum
lucimycine
lucimicina
lucimycin [inn]
lucimicina [inn-spanish]
leucensomycin
6,11,28-trioxatricyclo(22.3.1.05,7)octacosa-8,14,16,18,20-pentaene-25-carboxylic acid, 22-((3-amino-3,6-dideoxy-.beta.-d-mannopyranosyl)oxy)-12-butyl-1,3,26-trihydroxy-10-oxo-
lucensomycin [mi]
fi-1163
antibiotic fi-1163
1384655-66-6
DTXSID201016933

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" Our results suggest that the dose-related stimulatory, permeabilizing, and toxic effects of AmB most probably have distinct mechanisms of action and may be independent of one another."( Stimulatory, permeabilizing, and toxic effects of amphotericin B on L cells.
Brajtburg, J; Elberg, S; Kobayashi, GS; Medoff, G; Medoff, J; Schlessinger, D, 1984
)
0.27

Compound-Compound Interactions

ExcerptReferenceRelevance
"We compared the in vitro antifungal action of amphotericin B (AmB) used alone or in combination with a second polyene antibiotic or with miconazole or ketoconazole."( Antifungal action of amphotericin B in combination with other polyene or imidazole antibiotics.
Brajtburg, J; Kobayashi, D; Kobayashi, GS; Medoff, G, 1982
)
0.26

Dosage Studied

ExcerptRelevanceReference
" In dose-response studies, increases in cell membrane permeability, measured as the loss of K+ ions, occurred along with the stimulation of [3H]uridine incorporation into RNA."( Stimulatory, permeabilizing, and toxic effects of amphotericin B on L cells.
Brajtburg, J; Elberg, S; Kobayashi, GS; Medoff, G; Medoff, J; Schlessinger, D, 1984
)
0.27
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (30)

TimeframeStudies, This Drug (%)All Drugs %
pre-199025 (83.33)18.7374
1990's1 (3.33)18.2507
2000's0 (0.00)29.6817
2010's2 (6.67)24.3611
2020's2 (6.67)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (3.13%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other31 (96.88%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]